
|Videos|October 29, 2013
The Role of Regorafenib in Colorectal Cancer
Author(s)S. Gail Eckhardt, MD
S. Gail Eckhardt, MD, discusses the role of regorafenib in colorectal cancer.
Advertisement
S. Gail Eckhardt, MD, professor and head of the Division of Medical Oncology at the University of Colorado Denver and Health Sciences Center, discusses the role of regorafenib in colorectal cancer.
Clinical Pearls
- Regorafenib is a great option for community physicians who do not have access to clinical trials
- The approval of regorafenib gives physicians a level of activity to improve upon but is only an incremental improvement for patients
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5







































